Search

Search Constraints

You searched for: Author/Creator Alma, Eleonora

Search Results

1. Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment. Issue 6 (12th May 2022)

2. Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R‐CHOP‐14 for elderly patients with diffuse large B‐cell lymphoma. (29th March 2015)

3. PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma. Issue 3 (20th January 2022)

4. PD‐L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma. Issue 3 (20th January 2022)

5. SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation. (December 2020)

7. The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network 'Rete Ematologica del Lazio per i Linfomi' (RELLI). Issue 14 (6th December 2019)

8. The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL). Issue 5 (15th April 2020)

10. Vitamin D deficiency and supplementation in patients with aggressive B‐cell lymphomas treated with immunochemotherapy. (22nd December 2017)